IL1B and malaria: TNF, first described in 1975 for its in vivo capacity to kill tumor cells [23], was, six years later, shown to kill malaria parasites in vivo, and proposed, along with IL-1 (then known as LAF), to cause the disease complexities of malaria and sepsis [24,25].